unilad homepage
  • News
    • UK News
    • US News
    • World News
    • Crime
    • Health
    • Money
    • Sport
    • Travel
  • Film and TV
    • Netflix
  • Music
  • Tech
  • Features
  • Celebrity
  • Politics
  • Advertise
  • Terms
  • Privacy & Cookies
  • LADbible Group
  • LADbible
  • SPORTbible
  • GAMINGbible
  • Tyla
  • UNILAD Tech
  • FOODbible
  • License Our Content
  • About Us & Contact
  • Jobs
  • Latest
  • Archive
  • Topics A-Z
  • Authors
Facebook
Instagram
X
Threads
TikTok
YouTube
Submit Your Content
Weight Loss Jab Approved For Use In European Countries

Home> News

Updated 08:50 21 Mar 2022 GMTPublished 08:30 21 Mar 2022 GMT

Weight Loss Jab Approved For Use In European Countries

The European Medicines Agency has approved the use of Wegovy in EU countries

Anish Vij

Anish Vij

google discoverFollow us on Google Discover
Featured Image Credit: Alamy

Topics: UK News, Health

Anish Vij
Anish Vij

Anish is a Journalist at LADbible Group and is a GG2 Young Journalist of the Year 2024 finalist. He has a Master's degree in Multimedia Journalism and a Bachelor's degree in International Business Management. Apart from that, his life revolves around the ‘Four F’s’ - family, friends, football and food. Email: [email protected]

X

@Anish_Vij

Advert

Advert

Advert

A potential 'game changing' obesity drug has now been approved for use in EU countries.

The new 'weight loss injection' basically works by suppressing people's appetites, which will ultimately help people loose weight.

The European Medicines Agency (EMA) confirmed that the new drug called 'Wegovy' has been given the green light.

EMA say those who qualify for the jab will have 'a BMI of 30 kg/m² or greater (obesity) or a BMI of at least 27 kg/m² but less than 30 kg/m² (overweight) who have weight-related health problems (such as diabetes, high blood pressure, abnormal levels of fats in the blood, breathing problems during sleep called ‘obstructive sleep apnoea’ or a history of heart attack, stroke or blood vessel problems)'.

Advert

The way it works is, Wegovy would be 'injected once a week under the skin in the abdomen, thigh or upper arm'.

The EMA say that 'patients can administer the medicine themselves' and that 'the medicine can only be obtained with a prescription'.

Pexels

'Studies have shown that Wegovy is effective in helping people lose weight, with a significant proportion of them achieving at least a 5% weight reduction,' according to EMA.

Like with every drug, there can be side effects, the most common ones being 'headache, nausea (feeling sick), vomiting, diarrhoea, constipations and abdominal (belly) pain'. These side effects 'may affect more than 1 in 10 people'.

The agency added: 'Obesity can lead to severe health problems and many obese people experience difficulty trying to lose weight. Wegovy is effective at reducing weight, and the side effects are manageable.

'The European Medicines Agency decided that Wegovy’s benefits are greater than its risks and it can be authorised for use in the EU.'

Pexels

In the UK, Boots is now selling an NHS-approved injection, called Liraglutide (commonly known as Saxenda).

It's available to buy at Boots and Lloyds Pharmacy stores across the UK without a prescription.

The NHS website reads: 'Liraglutide is a weight loss medicine that works by making you feel fuller and less hungry.

'It's taken as an injection once a day. Your doctor or nurse will show you how to take it.

'You can usually only take liraglutide if it's prescribed for you by a specialist weight management service.'

If you have a story you want to tell, send it to UNILAD via [email protected]  

  • Fitness expert Jillian Michaels issues stark warning for weight loss drugs
  • Former Playboy model Kendra Wilkinson calls out celebs who aren't being honest about using weight loss drugs
  • Doctor explains 'weight-loss jab smell' as new side effect for Ozempic is revealed
  • 'Ozempic babies' warning issued as women taking weight loss jab issued vital advice

Choose your content:

Just now
15 mins ago
an hour ago
  • Getty Stock Images
    Just now

    New research explains the reason some people live to 100 and some don't

    The study focused on people over 100, and those between 30 and 60

    News
  • sumbulari/Instagram
    15 mins ago

    Woman, 26, with excessive itching diagnosed herself with cancer after being dismissed by doctors

    Sumbul Ari was advised to just 'moisturize' by a doctor when she expressed her concerns

    News
  • Getty Stock
    an hour ago

    Cruise ship workers expose the worst type of guests on board

    They shared some of the most difficult people they've encountered at work

    News
  • Getty Stock
    an hour ago

    Nutritionist explains why farts smell and when exactly you should be concerned

    Passing wind is perfectly normal, but here's when it can become a cause for concern

    News